These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21641114)

  • 1. BTX-A for persistent myofascial TMD pain: interpreting a small clinical trial with negative results.
    Nixdorf DR
    Pain; 2011 Sep; 152(9):1944-1945. PubMed ID: 21641114
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study, by Ernberg, Hedenberg-Magnusson, List, and Svensson.
    Janal MN; Raphael KG
    Pain; 2011 Sep; 152(9):2186-2187. PubMed ID: 21737201
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study.
    Ernberg M; Hedenberg-Magnusson B; List T; Svensson P
    Pain; 2011 Sep; 152(9):1988-1996. PubMed ID: 21514731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials.
    Chen YW; Chiu YW; Chen CY; Chuang SK
    Int J Oral Maxillofac Surg; 2015 Aug; 44(8):1018-26. PubMed ID: 25920597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin in the management of temporomandibular disorders: a systematic review.
    Thambar S; Kulkarni S; Armstrong S; Nikolarakos D
    Br J Oral Maxillofac Surg; 2020 Jun; 58(5):508-519. PubMed ID: 32143934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections.
    Abboud WA; Hassin-Baer S; Joachim M; Givol N; Yahalom R
    Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1417-1423. PubMed ID: 28521968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Local Anesthetic Versus Botulinum Toxin-A Injections for Myofascial Pain Disorders: A Systematic Review and Meta-Analysis.
    Ahmed S; Subramaniam S; Sidhu K; Khattab S; Singh D; Babineau J; Kumbhare DA
    Clin J Pain; 2019 Apr; 35(4):353-367. PubMed ID: 30589660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.
    Porta M
    Pain; 2000 Mar; 85(1-2):101-5. PubMed ID: 10692608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Effects of a Single Application of Botulinum Toxin Type A in Temporomandibular Myofascial Pain Patients: A Controlled Clinical Trial.
    De la Torre Canales G; Câmara-Souza MB; Poluha RL; de Figueredo OMC; Nobre BBS; Ernberg M; Conti PCR; Rizzatti-Barbosa CM
    Toxins (Basel); 2022 Oct; 14(11):. PubMed ID: 36355991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans.
    De Andrés J; Adsuara VM; Palmisani S; Villanueva V; López-Alarcón MD
    Reg Anesth Pain Med; 2010; 35(3):255-60. PubMed ID: 20921836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of Botulinum Toxin for the Treatment of Myofascial Pain in the Masticatory Muscles.
    Laskin DM
    Oral Maxillofac Surg Clin North Am; 2018 Aug; 30(3):287-289. PubMed ID: 30008341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of botulinum toxin A injection on the lateral pterygoid muscle in patients with a painful temporomandibular joint click: a randomized clinical trial study.
    Rezazadeh F; Esnaashari N; Azad A; Emad S
    BMC Oral Health; 2022 May; 22(1):217. PubMed ID: 35641993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of botulinum toxin in patients with myofascial pain related to temporomandibular joint disorders: A systematic review.
    Ramos-Herrada RM; Arriola-Guillén LE; Atoche-Socola KJ; Bellini-Pereira SA; Castillo AA
    Dent Med Probl; 2022; 59(2):271-280. PubMed ID: 35775414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myofascial pain.
    Malcmacher L
    Dent Today; 2013 Dec; 32(12):16. PubMed ID: 24494450
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of Localized and Referred Masticatory Myofascial Pain with Botulinum Toxin Injection.
    Montes-Carmona JF; Gonzalez-Perez LM; Infante-Cossio P
    Toxins (Basel); 2020 Dec; 13(1):. PubMed ID: 33374687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
    Seo HG; Bang MS; Chung SG; Jung SH; Lee SU
    Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical appraisal of the evidence for botulinum toxin type A in the treatment for cervico-thoracic myofascial pain syndrome.
    Desai MJ; Shkolnikova T; Nava A; Inwald D
    Pain Pract; 2014 Feb; 14(2):185-95. PubMed ID: 23692187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unclear results for the use of botulinum toxin therapy for TMD pain.
    Keenan JR
    Evid Based Dent; 2015 Dec; 16(4):122. PubMed ID: 26680526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of botulinum toxin on quality of life of patients with chronic myofascial pain.
    Miotto E; Salvatore Freitas KM; Mori AA; Valarelli FP; Gobbi de Oliveira RC; Oliveira RC
    Pain Manag; 2021 Sep; 11(5):583-593. PubMed ID: 33980033
    [No Abstract]   [Full Text] [Related]  

  • 20. A critical review of the use of botulinum toxin in orofacial pain disorders.
    Clark GT; Stiles A; Lockerman LZ; Gross SG
    Dent Clin North Am; 2007 Jan; 51(1):245-61, ix. PubMed ID: 17185069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.